(Q33456964)

English

A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 July 2017

A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people (English)

1 reference

Europe PubMed Central

26 July 2017

1 reference

based on heuristic

inferred from title

author name string

Magrath I

1

1 reference

Europe PubMed Central

26 July 2017

Sandlund J

2

1 reference

Europe PubMed Central

26 July 2017

Raynor A

3

1 reference

Europe PubMed Central

26 July 2017

Rosenberg S

4

1 reference

Europe PubMed Central

26 July 2017

Arasi V

5

1 reference

Europe PubMed Central

26 July 2017

Miser J

6

1 reference

Europe PubMed Central

26 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 1986

1 reference

Europe PubMed Central

26 July 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

26 July 2017

18 Suppl 2

1 reference

Europe PubMed Central

26 July 2017

S25-8

1 reference

Europe PubMed Central

26 July 2017

https://scigraph.springernature.com/pub.10.1007/bf00647446

0 references

Ifosfamide in experimental tumor systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of ifosfamide in refractory malignant diseases and uroprotection by mesna: results of a clinical phase II-study with 151 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[The CESS 81 cooperative Ewing sarcoma study of the Society for Pediatric Oncology: an interim report]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Chemotherapy in advanced sarcomas (author's transl)]

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anticancer spectrum of ifosfamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Results obtained with fractionated ifosfamide massive-dose treatment in generalized malignant tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/3815717

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00647446

1 reference

Europe PubMed Central

26 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33456964&oldid=1606854958"